Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.7K Sell
269
-1,285
-83% -$148K ﹤0.01% 340
2025
Q4
$33.9K Sell
1,554
-265
-15% -$24.9K ﹤0.01% 312
2025
Q3
$28K Buy
1,819
+1,277
+236% +$105K ﹤0.01% 326
2025
Q2
$42.6K Sell
542
-589
-52% -$46.8K ﹤0.01% 311
2025
Q1
$101K Sell
1,131
-454
-29% -$42.4K 0.01% 268
2024
Q4
$112K Sell
1,585
-157
-9% -$16.2K 0.01% 252
2024
Q3
$157K Sell
1,742
-78
-4% -$9.27K 0.02% 211
2024
Q2
$184K Buy
1,820
+709
+64% +$91.3K 0.02% 188
2024
Q1
$146K Hold
1,111
0.03% 186
2023
Q4
$121K Hold
1,111
0.02% 193
2023
Q3
$114K Sell
1,111
-100
-8% -$10.8K 0.02% 187
2023
Q2
$140K Hold
1,211
0.03% 152
2023
Q1
$129K Buy
1,211
+125
+12% +$13.5K 0.03% 160
2022
Q4
$120K Buy
+1,086
New +$111K 0.03% 193

Other funds holding MRK

Y.D. More Investments's MRK Position: Q1 2026 in Review

Y.D. More Investments reduced its Merck (MRK) stake by 83% in Q1 2026, selling an estimated $148K and leaving 269 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Y.D. More Investments first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $184K in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Y.D. More Investments held 269 shares of Merck worth $22.7K as of Q1 2026.
  • Y.D. More Investments sold 1,285 Merck shares in Q1 2026, an estimated $148K.
  • Merck made up ﹤0.01% of Y.D. More Investments's portfolio in Q1 2026, its #340 holding.
  • Y.D. More Investments first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Y.D. More Investments's Merck position peaked at $184K in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Y.D. More Investments's 13F filing for Q1 2026, filed 4 May 2026.